Sammartano, V. (2025) “Efficacy and safety of teclistamab followed by autologous stem cells transplant in functional high-risk and triple class refractory multiple myeloma”, Mediterranean Journal of Hematology and Infectious Diseases, 17(1), p. e2025051. doi: 10.4084/MJHID.2025.051.